These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. Mahairas GG, Sabo PJ, Hickey MJ, Singh DC, Stover CK. J Bacteriol; 1996 Mar; 178(5):1274-82. PubMed ID: 8631702 [Abstract] [Full Text] [Related]
3. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens. Brodin P, Majlessi L, Brosch R, Smith D, Bancroft G, Clark S, Williams A, Leclerc C, Cole ST. J Infect Dis; 2004 Jul 01; 190(1):115-22. PubMed ID: 15195250 [Abstract] [Full Text] [Related]
4. Bacterial artificial chromosome-based comparative genomic analysis identifies Mycobacterium microti as a natural ESAT-6 deletion mutant. Brodin P, Eiglmeier K, Marmiesse M, Billault A, Garnier T, Niemann S, Cole ST, Brosch R. Infect Immun; 2002 Oct 01; 70(10):5568-78. PubMed ID: 12228284 [Abstract] [Full Text] [Related]
10. Pathogenomic analyses of Mycobacterium microti, an ESX-1-deleted member of the Mycobacterium tuberculosis complex causing disease in various hosts. Orgeur M, Frigui W, Pawlik A, Clark S, Williams A, Ates LS, Ma L, Bouchier C, Parkhill J, Brodin P, Brosch R. Microb Genom; 2021 Feb 01; 7(2):. PubMed ID: 33529148 [Abstract] [Full Text] [Related]
11. Evaluation of Mycobacterium bovis double knockout mce2-phoP as candidate vaccine against bovine tuberculosis. García E, Bianco MV, Gravisaco MJ, Rocha RV, Blanco FC, Bigi F. Tuberculosis (Edinb); 2015 Mar 01; 95(2):186-9. PubMed ID: 25620706 [Abstract] [Full Text] [Related]
12. Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Pym AS, Brodin P, Majlessi L, Brosch R, Demangel C, Williams A, Griffiths KE, Marchal G, Leclerc C, Cole ST. Nat Med; 2003 May 01; 9(5):533-9. PubMed ID: 12692540 [Abstract] [Full Text] [Related]